Seng and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Seng (ginseng, panax), especially for people who are male, 60+ old, also take Melatonin, and have Chronic obstructive pulmonary disease.

The study is created by eHealthMe based on reports of 1,057 people who have side effects when taking Seng from the FDA, and is updated regularly.

What is Seng?

Seng has active ingredients of ginseng, panax. eHealthMe is studying from 1,152 Seng users. Check the latest studies of Seng.

On Jul, 30, 2026

1,057 people reported to have side effects when taking Seng.
Among them, 77 people (7.28%) died.

Among these 77 people:

What is the gender of people who died when taking Seng? *

female: 4.41 %
male: 95.59 %

What is the age of people who died when taking Seng? *

What are other drugs people take besides Seng? *

Melatonin: 62 people, 80.52%
Allopurinol: 61 people, 79.22%
Gabapentin: 61 people, 79.22%
Acetaminophen: 60 people, 77.92%
Ondansetron: 60 people, 77.92%
Vasopressin: 60 people, 77.92%
Metronidazole: 60 people, 77.92%
Aranesp: 60 people, 77.92%
Simvastatin: 59 people, 76.62%
Pyridoxine Hydrochloride: 59 people, 76.62%

What are other side effects people have before they died? *

Sepsis (a severe blood infection that can lead to organ failure and death): 58 people, 75.32%
Abdominal Distension: 56 people, 72.73%
Cardiogenic Shock (inadequate circulation of blood): 56 people, 72.73%
Stress And Anxiety: 56 people, 72.73%
Nausea And Vomiting: 56 people, 72.73%
Ventricular Fibrillation (abnormally irregular heart rhythm): 54 people, 70.13%
Blood Phosphorus Increased: 54 people, 70.13%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 54 people, 70.13%
Drowsiness: 53 people, 68.83%
Abdominal Pain: 52 people, 67.53%

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 61 people, 79.22%
Cardiogenic Shock (inadequate circulation of blood): 60 people, 77.92%
High Blood Cholesterol: 60 people, 77.92%
Diabetes: 60 people, 77.92%
Constipation: 60 people, 77.92%
Ventricular Fibrillation (abnormally irregular heart rhythm): 60 people, 77.92%
Iron Deficiency: 60 people, 77.92%
Nausea And Vomiting: 60 people, 77.92%
Dyspnea (difficult or laboured breathing): 60 people, 77.92%
Pulmonary Embolism (blockage of the main artery of the lung): 60 people, 77.92%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Seng:

Seng (1,152 reports)

Expand to all the drugs that have ingredients of ginseng, panax:

Death and drugs with ingredients of ginseng, panax

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Seng:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,119 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ginseng, panax (the active ingredients of Seng) and Seng (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.